Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin (Q44725496)

5 December 2017

title

Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin (English)

1 reference

5 December 2017

1 reference

1 reference

Kentaro Nakayama

1

1 reference

5 December 2017

Yuji Takebayashi

2

1 reference

5 December 2017

Satoru Nakayama

3

1 reference

5 December 2017

Kohkichi Hata

4

1 reference

5 December 2017

Ritsuto Fujiwaki

5

1 reference

5 December 2017

Manabu Fukumoto

6

1 reference

5 December 2017

Kohji Miyazaki

7

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

5 December 2017

1 reference

5 December 2017

volume

192

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

227-235

1 reference

5 December 2017

cites work

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

The p53 proto-oncogene can act as a suppressor of transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

Clinical implications of the p53 tumor-suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

p53 gene mutations and protein accumulation in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

P53 mutation does not affect prognosis in ovarian epithelial malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

Tumor-suppressor p53: implications for tumor development and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

A protein expression database for the molecular pharmacology of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900686-9

7 January 2021

10.1016/S0304-3835(02)00686-9

Identifiers

DOI

1 reference

5 December 2017

1 reference